1 Two hormones, one injection Tirzepatide activates both GIP and GLP-1 receptors, targeting appetite from two distinct biological pathways, something no single-agonist treatment can match
GIP : enhances insulin release and may further improve how the body stores and uses energy
The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Globe Newswire, Inc.
"We're at a point where we need to hold two truths: That GLP-1s are legitimate evidence-based treatments for obesity, but that they also sit inside our culture, which has intense weight pressure, weight stigma and eating disorder risk," she says
and Whitfield, T
With NBR Extensions, styling is no longer a distant dream